U.S. FDA Approval of Lombard's Aorfix

Aorfix is approved to treat patients with aneurysm neck angles of 0-90°, which represents most patients with abdominal aortic aneurysms ("AAA").

Aorfix is the only product approved in the US to treat patients with neck angulation of greater
than 60°.

Clinical data from Lombard's PYTHAGORAS study show that in the difficult to treat patients with neck angles of greater than 60% the product performed well.

Approval triggers both an equity and debt financing to support the US launch.

Lombard Medical Technologies plc

Lombard Medical Technologies plc
AAA stent graft manufacturer